Back
Myriad Genetics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
19
MYGN
Myriad Genetics
Last Price:
$4.16
Seasonality Move:
2.93%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Myriad Genetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.47 | Sell |
20-day SMA: | 6.24 | Sell |
50-day SMA: | 8.01 | Sell |
200-day SMA: | 16.83 | Sell |
8-day EMA: | 4.64 | Sell |
20-day EMA: | 5.9 | Sell |
50-day EMA: | 7.89 | Sell |
200-day EMA: | 14.18 | Sell |
Myriad Genetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.24 | Sell |
Relative Strength Index (14 RSI): | 25.15 | Sell |
Chaikin Money Flow: | 2202200 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5 - 8.18) | Sell |
Bollinger Bands (100): | (7.58 - 13.54) | Sell |
Myriad Genetics Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Myriad Genetics Stock
Is Myriad Genetics Stock a Buy?
-
Myriad Genetics share price is 4.11 while MYGN 8-day simple moving average is 4.47, which is a Sell signal.
-
The stock price of MYGN is 4.11 while Myriad Genetics 20-day SMA is 6.24, which makes it a Sell.
-
Myriad Genetics 50-day simple moving average is 8.01 while MYGN share price is 4.11, making it a Sell technically.
-
MYGN stock price is 4.11 and Myriad Genetics 200-day simple moving average is 16.83, creating a Sell signal.
MYGN Technical Analysis vs Fundamental Analysis
Sell
19
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy or a Sell?
-
Myriad Genetics stock is rated a SellThe current Myriad Genetics [MYGN] share price is $4.11. The Score for MYGN is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Myriad Genetics Stock Info
Market Cap:
378.8M
Price in USD:
4.11
Share Volume:
2.4M
Myriad Genetics 52-Week Range
52-Week High:
29.30
52-Week Low:
3.81
Sell
19
Myriad Genetics (MYGN)
is a Sell
Myriad Genetics Share Price Forecast
-
What is the Myriad Genetics stock price today?The Myriad Genetics stock price is 4.11 USD today.
-
Will MYGN stock go up or go down?Myriad Genetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Myriad Genetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Myriad Genetics is overvalued.
Is Myriad Genetics Stock a Buy?
-
Myriad Genetics share price is 4.11 while MYGN 8-day exponential moving average is 4.64, which is a Sell signal.
-
The stock price of MYGN is 4.11 while Myriad Genetics 20-day EMA is 5.90, which makes it a Sell.
-
Myriad Genetics 50-day exponential moving average is 7.89 while MYGN share price is 4.11, making it a Sell technically.
-
MYGN stock price is 4.11 and Myriad Genetics 200-day simple moving average is 14.18, creating a Sell signal.
Fundamental Analysis of Myriad Genetics
Is Myriad Genetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.14 per share, and an increase next year of $0.19 per share.
Technical Analysis of Myriad Genetics
Should I short Myriad Genetics stock?
-
MYGN Moving Average Covergence Divergence (MACD) indicator is -1.24, suggesting Myriad Genetics is a Sell
-
Myriad Genetics Relative Strength Index (RSI) is 25.15, which suggest Myriad Genetics is oversold
-
The Bollinger Bands (25) for Myriad Genetics is (5 - 8.18), which suggest Myriad Genetics is a Sell
-
The Bollinger Bands (100) for Myriad Genetics is (7.58 - 13.54), which suggest Myriad Genetics is a Sell
* Myriad Genetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.